Posted in | News | Chemistry

NACD Outlines Concerns for Toxic Chemicals Safety Act

In a letter addressed to House Energy and Commerce Committee Chairman Bobby Rush (D-IL) and Ranking Member Ed Whitfield (R-KY), National Association of Chemical Distributors (NACD) President Chris Jahn outlined the Association's concerns with H.R. 5820, the Toxic Chemicals Safety Act.

"NACD has advocated for a workable risk-based system that protects innovation and job creation," said Jahn. "Unfortunately, H.R. 5820 creates a framework that would place an impossible burden of proof on industry, hampering innovation and sacrificing jobs.

"Of particular concern to NACD is the treatment of mixtures in H.R. 5820. Over 70% of NACD Members provide customized chemical mixture processing services to a wide array of customers, including pharmaceuticals, water treatment, and electronics industries.  Despite certain improvements in the discussion draft, the treatment of mixtures and articles in the legislation, specifically in regards to the new chemicals program, is problematic in that it would create an unfathomable and unnecessary burden not just on chemical distributors, but the Environmental Protection Agency (EPA) as well."

NACD is also concerned with the potential market effects this legislation could have on chemical distribution companies and their over 750,000 customers.

Because of NACD members' vital role in the supply chain, "the data generation requirements for other areas of the supply chain, such as manufacturers and downstream users, will place an increasingly impossible burden on chemical distribution companies," said Jahn.  "The market pressures on top of the explicit requirements in H.R. 5820 would make the system unworkable for the industry."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.